Stockholm Medical Cannabis Conference

Three Phytocannabinoids Join Forces to Battle NOTCH1-Mutated T-Cell Lymphoblastic Acute Leukemia

Investigating the synergistic effects of cannabinoids 331-18A, CBDV, and CBD, this groundbreaking study targets NOTCH1-Mutated T-Cell Lymphoblastic Acute Leukemia (T-ALL) through the Integrated Stress Response Pathway. By exploring the ‘entourage effect’ with a combination of specific phytocannabinoids, the research opens up new therapeutic horizons, shedding light on the intricate molecular interactions and their potential in cancer treatment.